Business description
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. It provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum.
Management board & Supervisory board
| CEO |
| Brian McNamara |
| Management board |
| Tobias Hestler, Keith Choy, Filippo Lanzi, Mairéad Nayager, Lisa Paley, Franck Riot, Tamara Rogers, Bjarne Philip Tellmann, Ed Petter, Björn Timelin, Namrata Patel |
| Supervisory board |
| Sir Dave Lewis , Brian McNamara , Tobias Hestler, Mavinder Singh (Vindi) Banga , Marie-Anne Aymerich , Tracy Clarke, Dame Vivienne Cox, Asmita Dubey, Deirdre Mahlan, Bryan Supran, David (Dave) Denton |
Company data
| Name: |
Haleon PLC ORD GBP0.01 |
| Address: |
The Heights Building 5, First Floor The Heights,Surrey KT13 0NY |
| Phone: |
- |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.haleon.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
- |
